MedPath

Microgestin 24 Fe

These highlights do not include all the information needed to use Microgestin 24 Fe safely and effectively. See full prescribing information for Microgestin 24 FeMicrogestin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) for Oral UseInitial U.S. Approval:1968

Approved
Approval ID

77b9fd75-25cd-4fbc-ab32-f3857d7e2b08

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 12, 2020

Manufacturers
FDA

Mayne Pharma Inc.

DUNS: 867220261

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51862-648
Application NumberANDA202994
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate
Product Specifications
Effective DateOctober 12, 2020
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Microgestin 24 Fe - FDA Drug Approval Details